The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Apogee Therapeutics Inc shares valued at $394,041 were sold by Dambkowski Carl on Nov 06 ’24. At $59.12 per share, Dambkowski Carl sold 6,665 shares. The insider’s holdings dropped to 267,463 shares worth approximately $14.12 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, HENDERSON MICHAEL THOMAS sold 15,000 shares, netting a total of over 888,320 in proceeds. Following the sale of shares at $59.22 each, the insider now holds 1,339,487 shares.
Before that, HENDERSON MICHAEL THOMAS had added 15,000 shares to its account. In a trade valued at $888,388, the Officer bought Apogee Therapeutics Inc shares for $59.23 each.
As published in their initiating research note from BofA Securities on May 10, 2024, Apogee Therapeutics Inc [APGE] has been a Buy and the price target has been revised to $80. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. As of August 08, 2023, Wedbush has initiated its “an Outperform” rating for APGE. Earlier on August 08, 2023, TD Cowen initiated its rating. Their recommendation was “an Outperform” for APGE stock.
Analyzing APGE Stock Performance
During the last five days, there has been a drop of approximately -10.24%. Over the course of the year, Apogee Therapeutics Inc shares have jumped approximately 88.94%. Shares of the company reached a 52-week high of $72.29 on 03/13/24 and a 52-week low of $27.05 on 01/08/24. A 50-day SMA is recorded $54.73, while a 200-day SMA reached $49.58. Nevertheless, trading volume fell to 0.56 million shares from 0.29 million shares the previous day.
Support And Resistance Levels for Apogee Therapeutics Inc (APGE)
According to the 24-hour chart, there is a support level at 49.78, which, if violated, would cause prices to drop to 46.76. In the upper region, resistance lies at 57.55. The next price resistance is at 62.31. RSI (Relative Strength Index) is 43.75 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.50, which suggests the price will decrease in the coming days. Percent R is at 82.26%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
